Rise in Chronic Diseases is Driving the Growth of the MENA Effervescent Tablet Market

The MENA region is experiencing a sharp increase in Non-Communicable Diseases (NCDs) such as diabetes, cardiovascular disorders, and obesity, driven by sedentary lifestyles and changing dietary habits. According to the World Health Organization (WHO), NCDs account for over 70% of total deaths in several MENA countries, including Saudi Arabia, Egypt, and the UAE. This surge has accelerated demand for easy-to-consume, rapidly absorbed formulations like effervescent tablets that enhance patient compliance, especially among the elderly and chronically ill. These rising incidences of lifestyle-related disorders have significantly increased the demand for patient-friendly, fast-acting effervescent formulations, as they enhance drug absorption and compliance. Major healthcare players such as Bayer AG (Berocca) and Sanofi S.A. (Doliprane Effervescent) are expanding their product reach in GCC markets to cater to growing consumer demand for efficient and palatable dosage forms

Access Full Report @ https://www.databridgemarketresearch.com/reports/middle-east-and-north-africa-effervescent-tablet-market

Data Bridge Market Research analyzes that the Middle East and North Africa Effervescent Tablet Market is expected to reach USD 503.96 million by 2032 from USD 294.87 million in 2024, growing at a substantial CAGR of 6.9% in the forecast period of 2025 to 2032.

Key Findings of the Study

Increase in geriatric population with chronic diseases

The rising geriatric population across the Middle East and North Africa is significantly driving the effervescent tablet market, as older adults increasingly rely on convenient, fast-dissolving formulations to manage chronic conditions. Effervescent tablets are easier to swallow, offer better absorption, and provide quicker relief, making them highly suitable for elderly patients with difficulties taking conventional tablets. Growing cases of chronic illnesses such as osteoporosis, arthritis, cardiovascular diseases, and digestive disorders are further boosting the use of effervescent supplements and medications. Additionally, improved access to pharmacies, online platforms, and home healthcare services enables elderly individuals to manage daily nutritional needs and symptom relief more independently. Together, these factors are strengthening the adoption of effervescent tablets as a preferred dosage form among the aging population in the MENA region.

Report Scope and Market Segmentation

Segment Analysis

 Middle East and North Africa effervescent tablet market is segmented into eight notable segments which are based on products, methods, type, indication, population type, application, end user, distribution channel.

• On the basis of product, Middle East and North Africa effervescent tablet market is segmented into supplements, medication

In 2025, supplements segment is expected to dominate the  Middle East and North Africa Effervescent Tablet market

In 2025, the supplements segment is expected to dominate the market with 57.31% due to rising consumer awareness of preventive health, increasing demand for vitamin and mineral supplementation, and expanding availability of effervescent formats through retail and e-commerce channels. The region’s growing middle-class population, coupled with urban lifestyle changes and higher disposable incomes, is fueling consistent demand for multivitamins, vitamin C immunity boosters, and electrolyte supplements

• On the basis of methods, the Middle East and North Africa effervescent tablet market is segmented into wet granulation, dry methods, fluid bed spray granulation, granules, water‑based granulation/binding methods, organic solvents, others

In 2025, wet granulation  segment is expected to dominate the  Middle East and North Africa effervescent tablet market

In 2025, wet granulation segment is expected to dominate the market with a market share of 39.00% owing to its superior control over tablet uniformity, compressibility, and stability—factors critical to effervescent formulations where ingredient homogeneity and moisture sensitivity are key concerns. Wet granulation ensures optimal distribution of acids and alkalis, facilitating a controlled effervescent reaction upon dissolution while minimizing premature gas release during storage.

• On the basis of type, the Middle East and North Africa effervescent tablet market is segmented into over the counter, prescription. In 2025, over the counter segment is expected to dominate the market with a market share of 72.34%
• On the basis of indication, the Middle East and North Africa effervescent tablet market is segmented into pain management, gastric disorders, respiratory diseases, cold & flu, immunity booster, diuretics, others. In 2025, the pain management segment is expected to dominate the market with a market share of 31.90%
• On the basis of population type, the Middle East and North Africa effervescent tablet market is segmented into adults, children, geriatric. In 2025, the adults segment is expected to dominate the market with a market share of 68.14%
• On the basis of application, the Middle East and North Africa effervescent tablet market is segmented into pharmaceutical, dietary supplements, dental products, others. In 2025, the pharmaceutical segment is expected to dominate the market with a market share of 45.22%
• On the basis of end user, the Middle East and North Africa effervescent tablet market is segmented into hospitals, specialty clinics, home healthcare, others. In 2025, the hospitals segment is expected to dominate the market with a market share of 49.19%
• On the basis of distribution channel, the Middle East and North Africa effervescent tablet market is segmented into pharmacies, hypermarkets & supermarkets, multi‐level marketing channels, others. In 2025, the pharmacies segment is expected to dominate the market with a market share of 47.73%

Major Players

Data Bridge Market Research analyzes GSK plc. (U.K.), Bayer AG (Germany), Reckitt Benckiser Group plc. (U.S.), Sanofi S.A. (France), Bliss GVS Pharma Ltd. (India) among others as the major market players of the MENA effervescent tablet market.

Market Developments

• In June 2024, Bayer Consumer Health has introduced Berocca Mind, a new addition to its expert nutritional supplement range. The innovative formula features the extract of Spanish sage, known for supporting memory and mental performance, helping consumers manage daily cognitive demands effectively. Formulated with 12 essential vitamins and minerals, including all eight B vitamins, magnesium, zinc, and iron, the effervescent tablets are designed to reduce fatigue and maintain normal cognitive function. Available in refreshing Berry and Lemon flavours, Berocca Mind is free from sugar, caffeine, and artificial colours or flavours, making it suitable for vegans.
• In 2025, The EIPICO 3 Modular Buildings have been officially handed over, marking a significant milestone in the company’s advanced manufacturing expansion. These facilities were constructed using the Modular Building Concept, under which fully designed and equipped modules were fabricated at Pharmadule’s overseas facilities and subsequently transported to Egypt for installation at the production site.
• In 2025, A cooperation agreement has been signed between the Supreme Council of University Hospitals and EIPICO Pharmaceuticals to advance the quality and organization of healthcare services across Egypt’s university hospitals. This collaboration supports the Council’s mission to elevate healthcare standards and ensure that citizens experience efficient, high-quality medical care. The initiative reinforces the Council’s commitment to building strategic partnerships with national institutions, the private sector, and civil society to enhance the overall performance of the university hospital system. It also highlights EIPICO Pharmaceuticals’ strong sense of social responsibility, demonstrated through its contribution to healthcare provider training and public health awareness programs aimed at improving community well-being.
• In 2025, Hikma Pharmaceuticals PLC has signed a USD 250 million financing agreement with the International Finance Corporation (IFC) to support the company’s ongoing expansion across the Middle East and North Africa. The six-year arrangement strengthens a partnership that has spanned four decades, focusing on advancing local pharmaceutical manufacturing, improving the resilience of medicine supply chains, and broadening patient access to quality healthcare solutions in emerging markets.
• In 2024, Tabuk Pharmaceutical Manufacturing Company has entered into an exclusive licensing partnership with Hanmi, a distinguished South Korean pharmaceutical company. The collaboration aims to introduce a range of innovative, value-added medicines throughout the Kingdom of Saudi Arabia and the Middle East and North Africa (MENA) region, thereby strengthening the regional healthcare landscape and supporting improved patient outcomes. According to the agreement, Hanmi will oversee the development and production of the medicines, while Tabuk Pharmaceuticals will obtain the marketing authorization and handle product registration, importation, and promotional activities within the designated markets.

Regional Analysis

Geographically, the countries covered in the  Middle East and North Africa effervescent tablet market report is South Africa, Saudi Arabia, United Arab Emirates, Egypt, Israel, Algeria, Morocco, Tunisia, Libya, Sudan, Rest Of Middle East & North Africa.

As per Data Bridge Market Research analysis:

South Africa is expected to be the dominant and fastest growing country in the Middle East and North Africa effervescent tablet market

South Africa is expected to be the dominant and fastest growing country due to strong retail penetration, rising adoption of vitamin and mineral supplements, growing awareness of preventive healthcare, and higher purchasing power that supports demand for convenient effervescent formulations.

For more detailed information about the MENA Effervescent Tablet market report, click here – https://www.databridgemarketresearch.com/reports/middle-east-and-north-africa-effervescent-tablet-market